These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 3011898

  • 21. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Perez HD, Elfman F, Chenoweth D, Hooper C.
    J Immunol; 1986 Mar 01; 136(5):1813-9. PubMed ID: 3753994
    [Abstract] [Full Text] [Related]

  • 22. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine.
    Borish L, O'Reilly D, Klempner MS, Rocklin RE.
    J Immunol; 1986 Sep 15; 137(6):1897-903. PubMed ID: 3018081
    [Abstract] [Full Text] [Related]

  • 23. Superoxide anion production and phospholipase D-mediated generation of diacylglycerol are subnormal after N-formyl-methionyl-leucyl-phenylalanine stimulation of polymorphonuclear granulocytes in polycythemia vera.
    Samuelsson J, Hansson A, Rosendahl K, Palmblad J.
    J Lab Clin Med; 1993 Feb 15; 121(2):310-9. PubMed ID: 8381848
    [Abstract] [Full Text] [Related]

  • 24. Kinetics of N-formyl peptide receptor up-regulation during stimulation in human neutrophils.
    Norgauer J, Eberle M, Fay SP, Lemke HD, Sklar LA.
    J Immunol; 1991 Feb 01; 146(3):975-80. PubMed ID: 1988505
    [Abstract] [Full Text] [Related]

  • 25. Covalent affinity labeling, detergent solubilization, and fluid-phase characterization of the rabbit neutrophil formyl peptide chemotaxis receptor.
    Marasco WA, Becker KM, Feltner DE, Brown CS, Ward PA, Nairn R.
    Biochemistry; 1985 Apr 23; 24(9):2227-36. PubMed ID: 3995012
    [Abstract] [Full Text] [Related]

  • 26. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR.
    Rabiet MJ, Huet E, Boulay F.
    Eur J Immunol; 2005 Aug 23; 35(8):2486-95. PubMed ID: 16025565
    [Abstract] [Full Text] [Related]

  • 27. Diacylglycerol mass measurements in stimulated HL-60 phagocytes.
    Preiss JE, Bell RM, Niedel JE.
    J Immunol; 1987 Mar 01; 138(5):1542-5. PubMed ID: 3100640
    [Abstract] [Full Text] [Related]

  • 28. Development of receptors for leukotriene B4 on HL-60 cells induced to differentiate by 1 alpha,25-dihydroxyvitamin D3.
    Goldman DW, Olson DM, Payan DG, Gifford LA, Goetzl EJ.
    J Immunol; 1986 Jun 15; 136(12):4631-6. PubMed ID: 3011899
    [Abstract] [Full Text] [Related]

  • 29. Acute ethanol intoxication regulates f-met-leu-phe-induced chemotaxis and superoxide release by neutrophils and Kupffer cells through modulation of the formyl peptide receptor in the rat.
    Bautista AP, Elliott KE.
    Life Sci; 1994 Jun 15; 54(11):721-30. PubMed ID: 8107522
    [Abstract] [Full Text] [Related]

  • 30. Asparagine-linked glycosylation of cytochrome b558 large subunit varies in different human phagocytic cells.
    Kleinberg ME, Rotrosen D, Malech HL.
    J Immunol; 1989 Dec 15; 143(12):4152-7. PubMed ID: 2556477
    [Abstract] [Full Text] [Related]

  • 31. Acquisition of formyl peptide receptors during normal human myeloid differentiation.
    Sullivan R, Griffin JD, Malech HL.
    Blood; 1987 Oct 15; 70(4):1222-4. PubMed ID: 3651605
    [Abstract] [Full Text] [Related]

  • 32. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
    Mackin WM, Huang CK, Becker EL.
    J Immunol; 1982 Oct 15; 129(4):1608-11. PubMed ID: 6286772
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Chemotactic factor receptor activation transiently impairs the Ca2+ signaling capacity of beta 2 integrins on human neutrophils.
    Eierman D, Hellberg C, Sjölander A, Andersson T.
    Exp Cell Res; 1994 Nov 15; 215(1):90-6. PubMed ID: 7525325
    [Abstract] [Full Text] [Related]

  • 35. Functional integrity of cytokineplasts: specific chemotactic and capping responses.
    Dyett DE, Malawista SE, Van Blaricom G, Melnick DA, Malech HL.
    J Immunol; 1985 Sep 15; 135(3):2090-4. PubMed ID: 2991379
    [Abstract] [Full Text] [Related]

  • 36. Pharmacological profile of a bifunctional ligand of the formyl peptide receptor1 fused to the myc epitope.
    Charest-Morin X, Roy C, Fernandes MJ, Marceau F.
    Int Immunopharmacol; 2015 Mar 15; 25(1):229-34. PubMed ID: 25681283
    [Abstract] [Full Text] [Related]

  • 37. Myeloid differentiated HL-60 cells display specific leukotriene B4 binding sites.
    Gorman RR, Ruppel PL, Benjamin CW.
    Adv Prostaglandin Thromboxane Leukot Res; 1986 Mar 15; 16():165-77. PubMed ID: 3028094
    [Abstract] [Full Text] [Related]

  • 38. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
    Stenfeldt AL, Karlsson J, Wennerås C, Bylund J, Fu H, Dahlgren C.
    Biochem Pharmacol; 2007 Oct 01; 74(7):1050-6. PubMed ID: 17692291
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils.
    Atkinson YH, Marasco WA, Lopez AF, Vadas MA.
    J Clin Invest; 1988 Mar 01; 81(3):759-65. PubMed ID: 2830314
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.